This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
5 Reasons to Add Dave Stock to Your Portfolio Right Now
by Zacks Equity Research
DAVE's rising member value, disciplined underwriting and Coastal Community Bank transition add momentum to its 2026 growth setup.
DAVEPositive Net Change ATLCNegative Net Change CHYMNegative Net Change
fin-tech
Can V's New Threat Intelligence Platform Strengthen Fraud Prevention?
by Rajshree Sipani
Visa's new Threat Intelligence Platform helps financial institutions detect cyber risks early, strengthening fraud prevention and payment security.
VPositive Net Change MAPositive Net Change AXPPositive Net Change
artificial-intelligence business-services fin-tech finance payments
Should You Buy Evolent Health (EVH) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
EVHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Travel + Leisure Co. (TNL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TNLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Affirm Benefit From Its Bed Bath & Beyond Partnership?
by Rajshree Sipani
AFRM expands its BNPL reach through a Bed Bath & Beyond partnership, adding payment flexibility that could drive merchant growth and higher transaction volumes.
AFRMPositive Net Change VPositive Net Change PYPLPositive Net Change
fin-tech finance furniture-retailers internet payments retail saas
Visa Stock Surges 12.4% in a Month: Time to Buy, Hold or Sell?
by Kaibalya Pravo Dey
V's 12.4% rally in a month reflects strong payment growth, expanding blockchain initiatives and rising earnings estimates. Can the momentum continue?
VPositive Net Change MAPositive Net Change AXPPositive Net Change
business-services fin-tech finance payments
Block's Square AI Push: Can ChatGPT & Claude Expand Seller Discovery?
by Rohit Vasant Fatarpekar
XYZ's Square adds ChatGPT app and Claude plugin to help sellers get discovered in AI search and accept orders, expanding its commerce strategy.
XYZPositive Net Change PYPLPositive Net Change SHOPNegative Net Change
fin-tech
Upstart Stock Outlook Hinges on Funding, AI and Product Mix
by Moumita C. Chattopadhyay
Upstart's outlook rests on whether committed funding, AI automation and newer products can turn its loan rebound into steadier growth.
UPSTNegative Net Change AFRMPositive Net Change SOFINegative Net Change
fin-tech
Texas Roadhouse (TXRH)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TXRHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Upstart and the Lending Trends Shaping Its Next Growth Phase
by Moumita C. Chattopadhyay
Upstart is widening its AI lending platform into Auto, Home and HELOCs, but lower take rates and margin pressure keep execution in focus.
UPSTNegative Net Change AFRMPositive Net Change SOFINegative Net Change
fin-tech